ACBD6
Acyl-CoA-binding domain-containing protein 6
Also known as: ACBD6_HUMAN, MGC2404
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9BR61
- Gene
- ACBD6
- Ensembl
- ENSG00000230124
- Chromosome
- 1
- Canonical length
- 282 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Cytosol
OverviewNCBI Gene
Enables fatty-acyl-CoA binding activity. Located in cytoplasm and nucleus. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
282 residues, UniProt reviewed canonical sequence.
>Q9BR61|ACBD6
1 MASSFLPAGA ITGDSGGELS SGDDSGEVEF PHSPEIEETS CLAELFEKAA AHLQGLIQVA
61 SREQLLYLYA RYKQVKVGNC NTPKPSFFDF EGKQKWEAWK ALGDSSPSQA MQEYIAVVKK
121 LDPGWNPQIP EKKGKEANTG FGGPVISSLY HEETIREEDK NIFDYCRENN IDHITKAIKS
181 KNVDVNVKDE EGRALLHWAC DRGHKELVTV LLQHRADINC QDNEGQTALH YASACEFLDI
241 VELLLQSGAD PTLRDQDGCL PEEVTGCKTV SLVLQRHTTG KALocalizationUniProt · AlphaFold · HPA
Whether an antibody against ACBD6 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.34
- Highest tissue expression
- 42 nTPM
Expression across tissuesHPA
Tissue
- testis: 42 nTPM
- blood vessel: 32 nTPM
- ovary: 31 nTPM
- cervix: 28 nTPM
- skin: 28 nTPM
- endometrium: 28 nTPM
Single-cell type
- cytotrophoblasts: 370 nCPM
- retinal bipolar cells: 311 nCPM
- neutrophils: 311 nCPM
- somatotrophs: 294 nCPM
- thyrotrophs: 270 nCPM
- corticotrophs: 263 nCPM
Immune cell
- NK-cell: 28 nTPM
- myeloid DC: 22 nTPM
- intermediate monocyte: 20 nTPM
- memory B-cell: 18 nTPM
- plasmacytoid DC: 18 nTPM
- non-classical monocyte: 16 nTPM
Brain region
- cerebellum: 26 nTPM
- white matter: 23 nTPM
- hypothalamus: 21 nTPM
- amygdala: 19 nTPM
- basal ganglia: 19 nTPM
- cerebral cortex: 19 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about ACBD6.
Disease | AllUniProt
Conditions ACBD6 is implicated in, by any mechanism.
- Neurodevelopmental disorder with progressive movement abnormalities (NEDPM) MIM:620785
Disease | GeneticClinVar
7 pathogenic / likely-pathogenic of 80 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Neurodevelopmental disorder with progressive movement abnormalities
- Intellectual disability
- Inborn genetic diseases
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.13
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.11
- DepMap mean gene effect
- 0.08
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 14% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of ACBD6 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ACBD6 as an antibody target. Whether an autoantibody or antibody against ACBD6 could matter depends on whether native ACBD6 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ACBD6 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label ACBD6 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...